[Interferon-alpha therapy in chronic myelogenous leukemia].
Ohnishi
K
K
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D003561:Cytarabine / Q000627:therapeutic use; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*
D000970:Antineoplastic Agents; D016898:Interferon-alpha; D003561:Cytarabine